Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Dosell launches in Iceland through Lyfja and SKAND

IZAFE BPress release23.09.2026 klo 15.00

iZafe Group AB (publ) today announces that Dosell is now commercially available in Iceland through the pharmacy chain Lyfja and local distribution partner SKAND. The launch marks the commercial activation of the previously announced distribution partnership. The first Dosell unit has been put into use by a customer, and Dosell is available for demonstration at selected Lyfja pharmacies.

Dosell helps users take the right medication at the right time through reminders and automatic dispensing of multidose medication. If medication is not taken at the scheduled time, a notification can be sent to relatives or care professionals.

“At Lyfja, we focus on making medication management safer and easier. With the medication dispenser, our customers and their relatives gain greater security and a better overview of medication intake by helping ensure that the right medication is taken at the right time,” says Ólöf Helga Gunnarsdóttir, Director of Products at Lyfja.


“This is an important step as our distribution agreement is now translating into an actual market presence in Iceland. Our international expansion is built around strong local partners with established relationships, market knowledge and infrastructure. Together with SKAND and Lyfja, we are now making Dosell available to Icelandic consumers, making Iceland another concrete step in our Nordic expansion,” says Anders Segerström, CEO of iZafe Group AB.


Dosell will also be demonstrated at Lyfja’s “Heilsan til framtíðar” event at Harpa in Reykjavík on Friday, 25 September. Visitors will have the opportunity to see Dosell in action and learn more about the solution.

iZafe Group previously announced its distribution agreement with SKAND, which includes an initial order of 300 Dosell units with planned delivery during 2026. The current launch represents the commercial activation of that partnership and does not constitute a new order or a change to the company’s financial outlook.

More information about Dosell and Lyfja’s medication dispensing service is available at:
https://www.lyfja.is/thjonusta/lyfjaskoemmtun/

Contacts


Anders Segerström, Chief Executive Officer 
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm

E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group

About iZafe Group AB (publ.)


iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.

The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. The company’s Certified Adviser is DNB Carnegie Investment Bank AB. Further information is available at www.izafegroup.com

Image Attachments


Lyfja

Attachments


Dosell launches in Iceland through Lyfja and SKAND